Scarica l'app Stockscreener
4.64
4.72%
-0.23
Dopo l'orario di chiusura:
4.61
-0.03
-0.65%
Optimi Health Corp Borsa (OPTH) Ultime notizie
SRx Health Decided To Invest In A Psychedelic Drug Company That Just Went Public – Here’s What Aided The Decision - Stocktwits
Optimi Health Corp. - The Canadian Securities Exchange (CSE)
Optimi Health Corp. (OPTH) Stock: Surges 8% as Psilocybin Shipments to Australia Signal Growing Commercial Momentum - parameter.io
Optimi Health completes psilocybin export to Australia for patients with treatment-resistant depression - MSN
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression - Financial Times
Optimi Health (NASDAQ: OPTH) makes third psilocybin shipment for TRD - Stock Titan
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression - GlobeNewswire Inc.
Price to earnings forward of Optimi Health Corp. – CSE:OPTI - TradingView
Price to sales forward of Optimi Health Corp. – LSX:A411WC - TradingView
Optimi Health Corp. (OPTH) Cash From Operations (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Market Cap - Zacks Investment Research
Optimi Health (OPTH) Stock Trends and Sentiment 2026 - MarketBeat
OPTH Price Today: Optimi Health Corp. Stock Price, Quote & Chart | MEXC - MEXC
OPTH|Optimi Health Ord Shs|Price:4.060|Chg%:0.05 - TradingKey
Price to book ratio of Optimi Health Corp. – TRADEGATE:8BN0 - TradingView
Optimi Health Corp. (OPTH) Book Value - Zacks Investment Research
Optimi Health Corp. (OPTH) Earnings Yield (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Price To Free Cash Flow - Zacks Investment Research
Optimi Health Corp. (OPTH) Revenue (Quarterly) Yoy Growth - Zacks Investment Research
Optimi Health Corp. (OPTH) Free Cash Flow (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Total Expenses (TTM) - Zacks Investment Research
Optimi Health Corp. (OPTH) Shareholders Equity (Quarterly) - Zacks Investment Research
Optimi Health Corp. (OPTH) Net Income (Quarterly) - Zacks Investment Research
Optimi Health Corp. (OPTH) Ps Ratio (TTM) - Zacks Investment Research
Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research - GuruFocus
Inside the new tiny-dose psilocybin pills labs will test in studies - Stock Titan
Optimi Health (OPTH) Earnings Date and Reports 2026 - MarketBeat
Optimi Health completes production of microdose psilocybin products By Investing.com - Investing.com Nigeria
Optimi Health completes production of microdose psilocybin products - Investing.com
Optimi Health (NASDAQ: OPTH) debuts standardized psilocybin microdose capsules for research - Stock Titan
OPTH News | OPTIMI HEALTH CORP (NASDAQ:OPTH) - ChartMill
Why Optimi’s Ibogaine Initiative Could Open a New Growth Channel - Yahoo Finance
Optimi Health ships psilocybin to UK for clinical trial By Investing.com - Investing.com India
Optimi Health Completes First Export of Psilocybin to the United Kingdom for Phase 2 Clinical Trial - GuruFocus
Optimi Health ships psilocybin to UK for clinical trial - Investing.com
Optimi Health Completes First Psilocybin Export to UK for Planned Phase 2 Trial - citybuzz -
Optimi Health exports psilocybin to UK for clinical trial By Investing.com - Investing.com South Africa
Optimi Health exports psilocybin to UK for clinical trial - Investing.com UK
Optimi Health Completes First Export of Psilocybin to UK - marketscreener.com
Optimi Health Corp. Completes First Export of Psilocybin to the UK for Phase 2 Clinical Trial - Quiver Quantitative
0.15%
1.95%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):